Shares of Novo Nordisk, the Danish pharmaceutical giant behind Ozempic and Wegovy, fell in pre-market trading and on the ...

Danish pharmaceutical giant Novo Nordisk posted a sharp rise in second-quarter net profit Wednesday, but rising competition is weighing on sales of its diabetes and obesity treatments Ozempic and Wego ...

Novo Nordisk has announced the filing of 14 new lawsuits against the sale of unapproved compounded drugs claiming to contain semaglutide.

Investor Deadline: Investors who purchased or acquired Novo securities between May 7, 2025 through July 28, 2025 (the “Class Period”), may, no later than September 30, 2025, seek to be appointed as a ...

Ali Eastburn missed her son’s rehearsal dinner after her appendix burst while traveling, an incident she claims was caused by ...